SCHEMBL19082297

SCHEMBL19082297

c1ccc2cc(-c3c4ccccc4c(-c4ccc(-c5c6sc7ccccc7c6cc6c5sc5ccc7ccccc7c56)cc4)c4ccccc34)ccc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 2/20 0.36
NQO1 P15559 1/20 0.36
MAPT P10636 1/20 0.35
PTPN1 P18031 2/20 0.33
ALOX5 P09917 2/20 0.33
TNKS O95271 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
ATM Q13315 1/20 0.33
GPR3 P46089 1/20 0.32
S1PR4 O95977 2/20 0.31
S1PR5 Q9H228 2/20 0.31
PDE9A O76083 1/20 0.30
CYP1A1 P04798 1/20 0.30
CYP1B1 Q16678 1/20 0.30
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
RAB9A P51151 1/20 0.30
MAPK9 P45984 1/20 0.30
MAPK14 Q16539 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082135 0.95 NQO2 (0.36) NQO2NQO1MAPTPTPN1ALOX5
SCHEMBL19082242 0.92 TNKS (0.40) NQO2NQO1MAPTPTPN1ALOX5
SCHEMBL17944218 0.91 MAPT (0.41) MAPTPTPN1ALOX5TNKSTNKS2
SCHEMBL19082097 0.87 TNKS (0.40) NQO2NQO1MAPTPTPN1ALOX5
SCHEMBL17944636 0.85 ALOX5 (0.40) MAPTPTPN1ALOX5TNKSTNKS2
SCHEMBL17945470 0.85 MAPT (0.41) MAPTPTPN1ALOX5TNKSTNKS2
SCHEMBL17944232 0.85 TNKS (0.44) MAPTPTPN1ALOX5TNKSTNKS2
SCHEMBL19082276 0.84 ALOX5 (0.36) NQO2NQO1MAPTPTPN1ALOX5
SCHEMBL19082348 0.84 NQO2 (0.34) NQO2NQO1MAPTPTPN1TNKS
SCHEMBL19077356 0.84 NQO2 (0.36) NQO2NQO1MAPTPTPN1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 NQO2 2592/4885NQO1 576/4885MAPT 1294/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 NQO2 2592/4885NQO1 576/4885MAPT 1294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.